A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2024, v. 130, n. 7, p. 1131, doi. 10.1038/s41416-023-02436-2

By:

• Burris, Howard A.;
• Berlin, Jordan;
• Arkenau, Tobias;
• Cote, Gregory M.;
• Lolkema, Martijn P.;
• Ferrer-Playan, Jordi;
• Kalapur, Anup;
• Bolleddula, Jayaprakasam;
• Locatelli, Giuseppe;
• Goddemeier, Thomas;
• Gounaris, Ioannis;
• de Bono, Johann

Publication type:

Article